This significant morphological overlap necessitates meticulous clinicopathological correlation and a comprehensive immunohistochemical workup, as conventional markers such as CK7, ER, PR, and GATA3 lack specificity due to their frequent expression in breast carcinomas (5, 10–12). The gene discussed is ESR1; the disease is breast carcinoma.